UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma

British journal of cancer, 2018-02, Vol.118 (4), p.495-508

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View

Cancers, 2019-05, Vol.11 (5), p.679

2019

Link zum Volltext

Verfügbarkeit prüfen

Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor

Current treatment options in oncology, 2023-12, Vol.24 (12), p.1683-1702

2023

Link zum Volltext

Verfügbarkeit prüfen

EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC

International journal of molecular sciences, 2022-11, Vol.23 (21), p.13451

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report

International journal of molecular sciences, 2022-12, Vol.24 (1), p.602

2022

Link zum Volltext

Verfügbarkeit prüfen

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

BMC cancer, 2021-07, Vol.21 (1), p.1-859, Article 859

2021

Link zum Volltext

Verfügbarkeit prüfen

Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer

Biomedicine & pharmacotherapy, 2023-10, Vol.166, p.115389-115389, Article 115389

2023

Link zum Volltext

Verfügbarkeit prüfen

Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial

Biomolecules (Basel, Switzerland), 2021-11, Vol.11 (11), p.1626

2021

Link zum Volltext

Verfügbarkeit prüfen

Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review

International journal of molecular sciences, 2023-04, Vol.24 (8), p.7666

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience

BMC cancer, 2020-05, Vol.20 (1), p.422-12, Article 422

2020

Link zum Volltext

Verfügbarkeit prüfen

ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients

Clinical cancer research, 2016-08, Vol.22 (16), p.4225-4235

2016

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges

Current treatment options in oncology, 2022-09, Vol.23 (9), p.1303-1319

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers

Biomolecules (Basel, Switzerland), 2020-10, Vol.10 (11), p.1474

2020

Link zum Volltext

Verfügbarkeit prüfen

Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma

Frontiers in immunology, 2022-10, Vol.13, p.982196-982196

2022

Link zum Volltext

Verfügbarkeit prüfen

Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors

International journal of dermatology, 2021-07, Vol.60 (7), p.e278-e281

2021

Link zum Volltext

Verfügbarkeit prüfen

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies

BMC cancer, 2020-10, Vol.20 (1), p.1018-12, Article 1018

2020

Link zum Volltext

Verfügbarkeit prüfen

A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters

Cancers, 2021-05, Vol.13 (11), p.2587

2021

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

Thoracic cancer, 2023-01, Vol.14 (1), p.12-23

2023

Link zum Volltext

Verfügbarkeit prüfen

Precision Medicine in Cholangiocarcinoma: Past, Present, and Future

Life (Basel, Switzerland), 2022-06, Vol.12 (6), p.829

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Journal of the Formosan Medical Association, 2024-01, Vol.123 (1), p.7-15

2024

Link zum Volltext

Verfügbarkeit prüfen

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner

Biomolecules (Basel, Switzerland), 2020-11, Vol.10 (11), p.1529

2020

Link zum Volltext

Verfügbarkeit prüfen

Changes in and modifiable patient‐ and family caregiver‐related factors associated with cancer patients’ high self‐perceived burden to others at the end of life: A longitudinal study

European journal of cancer care, 2018-11, Vol.27 (6), p.e12942-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients

Thoracic cancer, 2022-07, Vol.13 (13), p.1888-1897

2022

Link zum Volltext

Verfügbarkeit prüfen

ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma

Cancers, 2018-12, Vol.11 (1), p.3

2018

Link zum Volltext

Verfügbarkeit prüfen

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

Therapeutic advances in respiratory disease, 2022, Vol.16, p.175346662211327-17534666221132731

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(117)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma

Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View

Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor

EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC

Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer

Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial

Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience

ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients

Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers

Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma

Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies

A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

Precision Medicine in Cholangiocarcinoma: Past, Present, and Future

Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner

Changes in and modifiable patient‐ and family caregiver‐related factors associated with cancer patients’ high self‐perceived burden to others at the end of life: A longitudinal study

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients

ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

Suchergebnisse filtern